SCHEMBL27237472

SCHEMBL27237472

COc1cc(C=NNC(=O)c2cc(-c3ccc(OC(C)C)cc3)ccn2)cc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ RAB9A P51151 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ FDPS P14324 1/20 0.46
▸ MGAM O43451 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ GAA P10253 2/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 3/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ AMY1A P0DUB6 1/20 0.42
▸ NPC1 O15118 4/20 0.42
▸ PKM P14618 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27237467 1.00 KMT2A (0.49) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL27237487 0.87 KMT2A (0.52) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL25002982 0.87 KMT2A (0.52) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL27237453 0.87 ALDH1A1 (0.49) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL30862206 0.87 ALDH1A1 (0.49) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL25002957 0.87 ALDH1A1 (0.49) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL30862203 0.86 AMY1A (0.50) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL25002959 0.86 AMY1A (0.50) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL27237399 0.86 AMY1A (0.50) KMT2AMEN1RAB9ASMN1; SMN2MAPT
SCHEMBL25003163 0.85 GCGR (0.50) KMT2AMEN1SMN1; SMN2MAPTMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 — — EP disclosed
Send feedback